EXPRESSION AND SIGNIFICANCE OF SERUM INTERLEUKIN-32, INTERLEUKIN-6, AND TUMOR NECROSIS FACTOR-α IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

EXPRESSION AND SIGNIFICANCE OF SERUM INTERLEUKIN-32, INTERLEUKIN-6, AND TUMOR NECROSIS FACTOR-α IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

Objective To investigate the expression levels of serum interleukin-32 (IL-32), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in patients with nonalcoholic fatty liver disease (NAFLD) and their correlation with the severity of NAFLD. Methods A total of 87 patients with NAFLD who attended...

Full description

Bibliographic Details
Main Author:	ZHU Shuxia, SUN Xutong, KONG Lingling, ZHANG Yuehua, CHEN Ge, ZHAO Hong
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Precision Medicine 2023-06-01
Series:	精准医学杂志
Subjects:	non-alcoholic fatty liver disease\|interleukin-6\|tumor necrosis factor-alpha\|interleukin-32\|liver function tests
Online Access:	https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/202303009.pdf

Similar Items

Proinflammatory interleukins 2, 6 and tumor necrosis factor alpha in patients with hypertension and diabetes mellitus depending on the presence of metabolic-associated liver steatosis
by: O.M. Radchenko, et al.
Published: (2024-05-01)

Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
by: Saira Rafaqat, et al.
Published: (2024-03-01)

Serum Levels of Tumor Necrosis Factor-α and Interleukins in Children with Congenital Heart Disease
by: Noor Mohammand Noori, et al.
Published: (2017-03-01)

The effect of eight-week yoga training on serum levels of interleukin 6, interleukin 10, tumor necrosis factor alpha and body composition in women with multiple sclerosis
by: Elham Maddah, et al.
Published: (2024-08-01)

Evaluation of interleukin 10, interleukin 1-beta, and tumor necrosis factor-alpha gene polymorphisms in patients with periodontitis and healthy controls
by: Leila Saremi, et al.
Published: (2022-12-01)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
by: Tomasz Kaczyński, et al.
Published: (2019-09-01)

Diagnostic accuracy of interleukin-6, interleukin-10 and tumor necrosis factor alpha cytokine levels in patients with mild cognitive impairment: systematic review and meta-analysis
by: Alana Mara Inácio de Aquino, et al.
Published: (2024-06-01)

Open-Label Clinical Trial on the Impact of Autologous Dendritic Cell Therapy on Albuminuria and Inflammatory Biomarkers (Interleukin-6, Interleukin-10, Tumor Necrosis Factor α) in Diabetic Kidney Disease (DKD)
by: Jonny, et al.
Published: (2024-12-01)

Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Abolghasem Hadinia, et al.
Published: (2019-12-01)

The effects of the basil (ocimum sanctum) treatment on the tumor necrosis factor-α and interleukin 1β release in the kidney tissue of the diabetic rats
by: Sevda ELİŞ YILDIZ, et al.
Published: (2021-04-01)

Study of serum cytokines (interleukin-6 and tumor necrosis factor-alpha) in acute leukemias
by: Divita Saxena, et al.
Published: (2022-01-01)

The role of the interleukin family in liver fibrosis
by: Zixin Zhang, et al.
Published: (2025-02-01)

Taurine Regulates the Expression of Interleukin −17/10 and Intestinal Flora and Protects the Liver and Intestinal Mucosa in a Nonalcoholic Fatty Liver Disease Rat Model
by: Zhu FL, et al.
Published: (2024-02-01)

Association of Interleukin-32α with Interleukin-35 and Transforming Growth Factor-β Produced by the Peripheral Blood Mononuclear Cells from Patients with Type 2 Diabetes Mellitus
by: Vida Sheikh, et al.
Published: (2023-06-01)

Serum levels of tumor necrosis factor-α, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis
by: Taner Bayraktaroğlu, et al.
Published: (2004-01-01)

Genetic signature of strong recent positive selection at interleukin-32 gene in goat
by: Akhtar Rasool Asif, et al.
Published: (2017-07-01)

Gestational Day-Dependent Expression of Interleukin-10 and Tumor Necrosis Factor-alpha in Porphyromonas gingivalis-infected Pregnant Rats
by: Banun Kusumawardani, et al.
Published: (2014-04-01)

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
by: Kronenberger Bernd, et al.
Published: (2012-09-01)

Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion
by: Juan Du, et al.
Published: (2022-08-01)

Interleukin-1β, interleukin-6 and interleukin-10 polymorphisms in Tunisian patients with colorectal cancer and liver metastasis
by: Hazgui Meriam, et al.
Published: (2022-01-01)

Interleukin-6 Receptor Blockade can Increase the Risk of Nonalcoholic Fatty Liver Disease: Indications From Mendelian Randomization
by: Shuxuan Li, et al.
Published: (2022-06-01)

Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD)
by: Darmadi Darmadi, et al.
Published: (2021-03-01)

EVALUATION OF INTERLEUKIN-6, LYMPHOTOXIN-α AND TNF-α GENE POLYMORPHISMS IN CHRONIC PERIODONTITIS.
by: Velitchka Dosseva-Panova, et al.
Published: (2015-09-01)

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
by: Saori Takamura, et al.
Published: (2022-04-01)

FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
by: V. E. Kulikov, et al.
Published: (2017-09-01)

POSSIBLE CHANGES IN THE CENTRAL HEMODYNAMICS IN PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS OF VIRAL ETIOLOGY WITH DIFFERENT LEVELS OF CYTOKINES
by: V. E Kulikov, et al.
Published: (2017-01-01)

Assessment of interleukin 32 as a novel biomarker for non-alcoholic fatty liver disease
by: Manal Sabry Mohamed, et al.
Published: (2022-04-01)

The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion
by: Danielle G Souza, et al.
Published: (2005-03-01)

INTERLEUKIN-8 AND INTERLEUKIN-1Α LEVELS IN THE GINGIVAL CREVICULAR FLUID OF PERIODONTITIS PATIENTS AND THEIR CORRELATION WITH PERIODONTAL POCKET DEPTH AND BLEEDING ON PROBING
by: Maheen Tariq, et al.
Published: (2022-06-01)

Association Between Expression of Interleukin-32 Gene and Various Helicobacter pylori Virulence Factors in Human Infected Gastric Biopsy
by: Heshmat Shahi, et al.
Published: (2020-07-01)

Impedimetric Detection of Femtomolar Levels of Interleukin 6, Interleukin 8, and Tumor Necrosis Factor Alpha Based on Thermally Modified Nanotubular Titanium Dioxide Arrays
by: Katarzyna Arkusz, et al.
Published: (2020-11-01)

Detection and Role of Some Interleukins and Tumor Necrotic Factor Alpha among Patients with Tuberculosis
by: Wael Rasheed Obaead Alfatlawi, et al.
Published: (2024-12-01)

Important Roles of Interleukin-36, Interleukin-37, and Interleukin-38 Cytokines in the Pathogenesis of Rosacea
by: Alper Ekinci, et al.
Published: (2024-06-01)

Aqueous humor levels of different interleukins 1-β, 2, 6 and 10, tumor necrosis factor-α and vascular endothelial growth factor in uveitis treated with adalimumab
by: María Luisa Hernández Garfella, et al.
Published: (2015-01-01)

Can the interleukin TNF-α be used as a biomarker for pulp necrosis?
by: Carlos Wesley Lopes Brasil da Silva, et al.
Published: (2025-02-01)

Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-α levels in drug-naive individuals with first-episode schizophrenia
by: Xiaofeng Zhao, et al.
Published: (2024-10-01)

The Association between Interleukin-6 and Mean Platelet Volume Levels in Central Obesity with or without Non-Alcoholic Fatty Liver Disease
by: Linda Rotty, et al.
Published: (2020-12-01)

On assessing risks of developing and progressing non-alcoholic fatty liver disease using TNF-α, IL6, and VEGF factors and polymorphisms of their genes
by: I.A. Bulatova, et al.
Published: (2022-03-01)

Influence of glucoregulation quality on c-reactive protein, interleukin-6 and tumor necrosis factor-α level in patients with diabetes type 1
by: Mitrović Milena, et al.
Published: (2011-01-01)

Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis
by: Obradović Dragana, et al.
Published: (2012-01-01)